UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000016702
Receipt No. R000013429
Official scientific title of the study Photodynamic diagnosis by using 5-aminolevulinic acid in pancreaticobiliary neoplasm
Date of disclosure of the study information 2015/03/05
Last modified on 2016/04/10 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Photodynamic diagnosis by using 5-aminolevulinic acid in pancreaticobiliary neoplasm
Title of the study (Brief title) Diagnosis using 5-aminolevulinic acid in pancreaticobiliary neoplasm
Region
Japan

Condition
Condition Pancreaticobiliary tumor
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To evaluate the diagnostic ability of 5-aminolevulinic acid in pancreaticobiliary neoplasm
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes Diagnostic accuracy of 5-aminolevulinic acid in pancreaticobiliary neoplasm
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 A single oral administration of 5-aminolevulinic acid (1g)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Patients who have an abnormality of biliary tree and/or pancreas.
2. Patients who provide a written informed consent.
Key exclusion criteria 1. Patients with porphyria.
2. Patients with hypersensitivity to 5-aminolevulinic acid or porphyrins.
3. In cases of known or suspected pregnancy or woman who are breast-feeding.
4. Patients who doctors regard as inappropriate ones for the enrollment due to some reasons.
Target sample size 100

Research contact person
Name of lead principal investigator Tsukasa Ikeura
Organization Kansai Medical University
Division name The Third Department of Internal Medicine
Address 2-5-1, Shinmachi, Hirakata, Osaka, Japan
TEL 072-804-0101
Email ikeurat@hirakata.kmu.ac.jp

Public contact
Name of contact person Tsukasa Ikeura
Organization Kansai Medical University
Division name The Third Department of Internal Medicine
Address 2-5-1, Shimachi, Hirakata
TEL 072-804-0101
Homepage URL
Email ikeurat@hirakata.kmu.ac.jp

Sponsor
Institute Kansai Medical University
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 03 Month 05 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2013 Year 04 Month 01 Day
Anticipated trial start date
2013 Year 07 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 03 Month 04 Day
Last modified on
2016 Year 04 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/icdr_e/ctr_view.cgi?recptno=R000013429